These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38516785)

  • 1. Cost-effectiveness of active tuberculosis screening among high-risk populations in low tuberculosis incidence countries: a systematic review, 2008 to 2023.
    Gogichadze N; Sagrera A; Vicente JÁ; Millet JP; López-Seguí F; Vilaplana C
    Euro Surveill; 2024 Mar; 29(12):. PubMed ID: 38516785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and cost effectiveness of screening immigrants schemes for tuberculosis (TB) on arrival from high TB endemic countries to low TB prevalent countries.
    Sanneh AF; Al-Shareef AM
    Afr Health Sci; 2014 Sep; 14(3):663-71. PubMed ID: 25352886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
    Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P
    Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review of cost and cost-effectiveness of different TB-screening strategies.
    Nienhaus A; Schablon A; Costa JT; Diel R
    BMC Health Serv Res; 2011 Sep; 11():247. PubMed ID: 21961888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target prioritization and strategy selection for active case-finding of pulmonary tuberculosis: a tool to support country-level project planning.
    Nishikiori N; Van Weezenbeek C
    BMC Public Health; 2013 Feb; 13():97. PubMed ID: 23374118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of interferon-gamma release assay for systematic tuberculosis screening of healthcare workers in low-incidence countries.
    Kowada A; Takasaki J; Kobayashi N
    J Hosp Infect; 2015 Feb; 89(2):99-108. PubMed ID: 25559158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost Effectiveness of Preventive Treatment for Tuberculosis in Special High-Risk Populations.
    Diel R; Lampenius N; Nienhaus A
    Pharmacoeconomics; 2015 Aug; 33(8):783-809. PubMed ID: 25774015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis.
    Pooran A; Booth H; Miller RF; Scott G; Badri M; Huggett JF; Rook G; Zumla A; Dheda K
    BMC Pulm Med; 2010 Feb; 10():7. PubMed ID: 20170555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic Evaluation of Screening Strategy for Latent Tuberculosis Infection (LTBI) in Contacts of Tuberculosis Patients: Systematic Review and Quality Assessment.
    Yoopetch P; Chitpim N; Jittikoon J; Udomsinprasert W; Thavorncharoensap M; Youngkong S; Praditsitthikorn N; Mahasirimongkol S; Chaikledkaew U
    Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36294107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis.
    Schwartzman K; Menzies D
    Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):780-9. PubMed ID: 10712322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-based evaluation of immigrant tuberculosis screening using interferon γ release assays and tuberculin skin testing: observational study and economic analysis.
    Pareek M; Bond M; Shorey J; Seneviratne S; Guy M; White P; Lalvani A; Kon OM
    Thorax; 2013 Mar; 68(3):230-9. PubMed ID: 22693179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of adding tuberculosis household contact investigation on passive case-finding strategy in Southwestern Uganda.
    Odongo D; Omech B; Acanga A
    PLoS One; 2023; 18(12):e0288761. PubMed ID: 38127969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review.
    Greenaway C; Pareek M; Abou Chakra CN; Walji M; Makarenko I; Alabdulkarim B; Hogan C; McConnell T; Scarfo B; Christensen R; Tran A; Rowbotham N; van der Werf MJ; Noori T; Pottie K; Matteelli A; Zenner D; Morton RL
    Euro Surveill; 2018 Apr; 23(14):. PubMed ID: 29637889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis screening costs and cost-effectiveness in high-risk groups: a systematic review.
    Alsdurf H; Empringham B; Miller C; Zwerling A
    BMC Infect Dis; 2021 Sep; 21(1):935. PubMed ID: 34496804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis screening of travelers to higher-incidence countries: a cost-effectiveness analysis.
    Tan M; Menzies D; Schwartzman K
    BMC Public Health; 2008 Jun; 8():201. PubMed ID: 18534007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of service models and organisational structures supporting tuberculosis identification and management in hard-to-reach populations in countries of low and medium tuberculosis incidence: a systematic review.
    Heuvelings CC; Greve PF; de Vries SG; Visser BJ; Bélard S; Janssen S; Cremers AL; Spijker R; Shaw E; Hill RA; Zumla A; Sandgren A; van der Werf MJ; Grobusch MP
    BMJ Open; 2018 Sep; 8(9):e019642. PubMed ID: 30196265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of interferon-gamma release assays for tuberculosis screening in nursing homes.
    Kowada A
    Epidemiol Infect; 2016 Nov; 144(15):3215-3225. PubMed ID: 27412626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis.
    Oxlade O; Schwartzman K; Menzies D
    Int J Tuberc Lung Dis; 2007 Jan; 11(1):16-26. PubMed ID: 17217125
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.